Related Experiment Videos

Assessment of stable ischemic heart disease. Which tests are best for which patients?

C J Lavie1, H O Ventura, J P Murgo

  • 1Ochsner Clinic, New Orleans, LA 70121.

Postgraduate Medicine
|January 1, 1991
PubMed

Insights

Understanding risk factors, myocardial ischemia pathogenesis, and noninvasive tests is crucial for managing coronary artery disease (CAD). While coronary angiography is standard, risk assessment and noninvasive data often better guide prognosis and treatment for CAD patients.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Coronary artery disease (CAD) management requires understanding risk factors and disease mechanisms.
  • Myocardial ischemia is a key pathological process in CAD.

Purpose of the Study:

  • To emphasize the importance of risk factor assessment and noninvasive testing in CAD management.
  • To compare the prognostic and management value of noninvasive data versus coronary angiography.

Main Methods:

  • Review of risk factors for CAD.
  • Analysis of the pathogenesis of myocardial ischemia.
  • Evaluation of noninvasive and invasive diagnostic tests for CAD.

Main Results:

  • Risk factor assessment, medical history, and noninvasive tests provide crucial prognostic information.
  • Data from noninvasive evaluations can be more impactful than coronary angiography alone for patient management.
  • Coronary angiography, while the gold standard for diagnosis, may not solely dictate patient prognosis and treatment direction.

Conclusions:

  • Comprehensive patient evaluation, including risk factors and noninvasive testing, is essential for effective CAD management.
  • Noninvasive data significantly contributes to defining prognosis and guiding therapeutic strategies in patients with suspected or known CAD.
  • Integrating information from various sources optimizes patient care beyond relying solely on invasive diagnostic procedures.

Related Concept Videos